AGIO Agios Pharmaceuticals, Inc. - Common Stock
Informazioni su Agios Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Leggi di più
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
AGIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
AGIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
AGIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 5 31,2%
- Compra 7 43,8%
- Mantieni 4 25,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
8 analisti · 2026-08-16Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.69 | $-1.70 | 0.01% |
| 31 Marzo 2026 | $-1.69 | $-1.84 | 0.15% |
| 31 Dicembre 2025 | $-1.86 | $-1.99 | 0.13% |
| 30 Settembre 2025 | $-1.78 | $-1.94 | 0.16% |
| 30 Giugno 2025 | $-1.93 | $-1.84 | -0.09% |
| 31 Marzo 2025 | $-1.55 | $-1.82 | 0.27% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
Tassi di Crescita 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
Stato Patrimoniale 20
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
Flusso di cassa 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $54M | $36M | $27M | $14M | $0 |
| Margine Operativo % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Utile netto | $-413M | $674M | $-352M | $-232M | $1.60B |
| EPS Diluito | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-377M | $-392M | $-297M | $-314M | $-413M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 264 filer · $2.0B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 46 (+12 vs trimestre precedente) | 30 (-3 vs trimestre precedente) | 95 (+17 vs trimestre precedente) | 62 (-27 vs trimestre precedente) | +12.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219.594.714 | 5.917.400 | 11,17% | Azioni |
| STATE STREET CORP | $131.144.972 | 3.533.633 | 6,67% | Azioni |
| Lynx1 Capital Management LP | $126.505.652 | 3.408.937 | 6,43% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.552.091 | 2.898.197 | 5,47% | Azioni |
| ARMISTICE CAPITAL, LLC | $104.279.100 | 2.810.000 | 5,30% | Opzione Call |
| VANGUARD CAPITAL MANAGEMENT LLC | $99.523.268 | 2.681.845 | 5,06% | Azioni |
| ARMISTICE CAPITAL, LLC | $89.064.000 | 2.400.000 | 4,53% | Azioni |
| Erste Asset Management GmbH | $81.972.396 | 2.154.900 | 4,17% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78.332.000 | 2.110.809 | 3,98% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51.046.957 | 1.375.558 | 2,60% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $50.151.466 | 1.351.093 | 2,55% | Azioni |
| ADAR1 Capital Management, LLC | $47.799.647 | 1.288.053 | 2,43% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $44.225.805 | 1.191.749 | 2,25% | Azioni |
| GOLDMAN SACHS GROUP INC | $36.642.971 | 987.415 | 1,86% | Azioni |
| D. E. Shaw & Co., Inc. | $34.087.168 | 918.544 | 1,73% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30.078.768 | 810.530 | 1,53% | Azioni |
| Foresite Capital Management VI LLC | $29.131.350 | 785.000 | 1,48% | Azioni |
| CITADEL ADVISORS LLC | $26.154.683 | 704.788 | 1,33% | Azioni |
| Parkman Healthcare Partners LLC | $24.828.297 | 669.046 | 1,26% | Azioni |
| SCS Capital Management LLC | $22.742.864 | 612.850 | 1,16% | Azioni |
| Qube Research & Technologies Ltd | $22.178.346 | 597.638 | 1,13% | Azioni |
| Defilade Capital Management, L.P. | $20.293.529 | 546.848 | 1,03% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.969.930 | 538.128 | 1,02% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $19.905.062 | 536.380 | 1,01% | Azioni |
| Rock Springs Capital Management LP | $19.763.413 | 532.563 | 1,01% | Azioni |
| Schonfeld Strategic Advisors LLC | $19.300.279 | 520.083 | 0,98% | Azioni |
| Point72 Asset Management, L.P. | $18.790.426 | 506.344 | 0,96% | Azioni |
| JANE STREET GROUP, LLC | $18.280.312 | 492.598 | 0,93% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $14.690.661 | 395.868 | 0,75% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $13.876.579 | 373.931 | 0,71% | Azioni |
| KENNEDY CAPITAL MANAGEMENT LLC | $13.850.565 | 373.230 | 0,70% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $13.342.901 | 359.550 | 0,68% | Azioni |
| Squarepoint Ops LLC | $11.917.431 | 321.138 | 0,61% | Azioni |
| JPMORGAN CHASE & CO | $11.853.074 | 309.008 | 0,60% | Azioni |
| Ensign Peak Advisors, Inc | $11.045.049 | 297.630 | 0,56% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $9.996.803 | 269.383 | 0,51% | Azioni |
| ALGERT GLOBAL LLC | $9.203.540 | 248.007 | 0,47% | Azioni |
| JANE STREET GROUP, LLC | $7.974.939 | 214.900 | 0,41% | Opzione Put |
| Palo Alto Investors LP | $7.926.733 | 213.601 | 0,40% | Azioni |
| Tetragon Partners GP Ltd | $7.629.037 | 205.579 | 0,39% | Azioni |
| AXA Investment Managers S.A. | $7.131.875 | 177.675 | 0,36% | Azioni |
| Cutter Capital Management, LP | $6.895.755 | 235.350 | 0,35% | Azioni |
| BlackRock, Inc. | $6.545.388 | 176.378 | 0,33% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.334.677 | 170.700 | 0,32% | Opzione Call |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6.306.139 | 169.931 | 0,32% | Azioni |
| FIRST TRUST ADVISORS LP | $6.144.933 | 165.587 | 0,31% | Azioni |
| Ishara Investments LP | $6.086.040 | 164.000 | 0,31% | Azioni |
| GROUP ONE TRADING LLC | $5.640.497 | 151.994 | 0,29% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $5.562.269 | 149.886 | 0,28% | Azioni |
| BANK OF AMERICA CORP /DE/ | $5.505.083 | 148.345 | 0,28% | Azioni |
| MARSHALL WACE, LLP | $5.150.868 | 138.800 | 0,26% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.080.359 | 136.900 | 0,26% | Opzione Put |
| AMERICAN CENTURY COMPANIES INC | $4.991.740 | 134.512 | 0,25% | Azioni |
| Man Group plc | $4.617.931 | 124.439 | 0,23% | Azioni |
| ArrowMark Colorado Holdings LLC | $4.368.367 | 117.714 | 0,22% | Azioni |
| Pictet Asset Management Holding SA | $4.247.606 | 111.861 | 0,22% | Azioni |
| Swiss National Bank | $4.143.703 | 111.660 | 0,21% | Azioni |
| CAPITAL FUND MANAGEMENT S.A. | $3.862.408 | 104.080 | 0,20% | Azioni |
| Assenagon Asset Management S.A. | $3.857.770 | 103.955 | 0,20% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.831 | 99.726 | 0,19% | Azioni |
| Knott David M Jr | $3.527.602 | 95.058 | 0,18% | Azioni |
| Trexquant Investment LP | $3.471.232 | 93.539 | 0,18% | Azioni |
| CITADEL ADVISORS LLC | $3.402.987 | 91.700 | 0,17% | Opzione Call |
| Jain Global LLC | $3.401.020 | 91.647 | 0,17% | Azioni |
| Caligan Partners LP | $3.339.900 | 90.000 | 0,17% | Opzione Call |
| CITADEL ADVISORS LLC | $3.295.368 | 88.800 | 0,17% | Opzione Put |
| CITIGROUP INC | $3.182.331 | 85.754 | 0,16% | Azioni |
| RHUMBLINE ADVISERS | $2.948.045 | 79.441 | 0,15% | Azioni |
| Bank of New York Mellon Corp | $2.916.846 | 78.600 | 0,15% | Azioni |
| Campbell & CO Investment Adviser LLC | $2.712.555 | 73.095 | 0,14% | Azioni |
| Exome Asset Management LLC | $2.616.255 | 70.500 | 0,13% | Azioni |
| Edgestream Partners, L.P. | $2.604.936 | 70.195 | 0,13% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $2.441.059 | 65.779 | 0,12% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.319.520 | 68.564 | 0,12% | Azioni |
| TWO SIGMA ADVISERS, LP | $2.319.144 | 85.200 | 0,12% | Azioni |
| ALPS ADVISORS INC | $2.228.789 | 60.059 | 0,11% | Azioni |
| Seven Fleet Capital Management LP | $2.111.559 | 56.900 | 0,11% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $2.092.859 | 61.864 | 0,11% | Azioni |
| Rafferty Asset Management, LLC | $2.062.574 | 55.580 | 0,10% | Azioni |
| Engineers Gate Manager LP | $2.000.674 | 53.912 | 0,10% | Azioni |
| WELLS FARGO & COMPANY/MN | $1.935.843 | 52.165 | 0,10% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.931.576 | 52.050 | 0,10% | Azioni |
| XTX Topco Ltd | $1.869.082 | 50.366 | 0,10% | Azioni |
| Caption Management, LLC | $1.855.500 | 50.000 | 0,09% | Opzione Call |
| Tetragon Partners GP Ltd | $1.855.500 | 50.000 | 0,09% | Opzione Call |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.846.742 | 49.764 | 0,09% | Azioni |
| BARCLAYS PLC | $1.725.651 | 46.501 | 0,09% | Azioni |
| Quantinno Capital Management LP | $1.614.805 | 43.514 | 0,08% | Azioni |
| MARTINGALE ASSET MANAGEMENT L P | $1.596.064 | 43.009 | 0,08% | Azioni |
| IEQ CAPITAL, LLC | $1.499.392 | 40.404 | 0,08% | Azioni |
| Kodai Capital Management LP | $1.485.276 | 50.692 | 0,08% | Azioni |
| Virtus Investment Advisers, LLC | $1.464.843 | 39.473 | 0,07% | Azioni |
| Caption Management, LLC | $1.456.530 | 39.249 | 0,07% | Azioni |
| JANE STREET GROUP, LLC | $1.451.001 | 39.100 | 0,07% | Opzione Call |
| FMR LLC | $1.446.325 | 38.974 | 0,07% | Azioni |
| Aquatic Capital Management LLC | $1.433.448 | 38.627 | 0,07% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.400.049 | 37.727 | 0,07% | Azioni |
| VANGUARD GROUP INC | $1.308.928 | 48.087 | 0,07% | Azioni |
| EDGEWOOD MANAGEMENT LLC | $1.298.850 | 35.000 | 0,07% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.298.776 | 34.998 | 0,07% | Azioni |
Insider aziendali 33 insider · 12 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 Giugno 2026 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 18 Giugno 2026 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 Aprile 2019 A | 12.374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 04 Gennaio 2016 M | 120.834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 Giugno 2026 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 18 Giugno 2026 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 18 Giugno 2026 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 05 Aprile 2019 M | 26.511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 01 Aprile 2019 M | 7.238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 04 Marzo 2019 M | 10.941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 22 Febbraio 2019 A | 2.796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 Febbraio 2016 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | Direttore | 18 Giugno 2026 A | 10.865 | 0 | 0 | $0 |
| Rahul D. Ballal | Direttore | 18 Giugno 2026 A | 15.230 | 0 | 0 | $0 |
| David Scadden | Direttore | 18 Giugno 2026 A | 20.419 | 0 | 0 | $0 |
| Maykin Ho | Direttore | 18 Giugno 2026 A | 19.848 | 0 | 0 | $0 |
| Cynthia Smith | Direttore | 18 Giugno 2026 A | 15.230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Direttore | 18 Giugno 2026 A | 154.156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | Direttore | 18 Giugno 2026 A | 10.284 | 0 | 0 | $0 |
| Jeffrey D Capello | Direttore | 18 Giugno 2026 A | 10.865 | 0 | 0 | $0 |
| Paul J Clancy | Direttore | 31 Maggio 2019 M | 1.400 | 0 | 0 | $0 |
| Ian T Clark | Direttore | 31 Maggio 2019 M | 1.400 | 0 | 0 | $0 |
| John Maraganore | Direttore | 31 Maggio 2019 M | 37.609 | 0 | 0 | $0 |
| David P Schenkein | Direttore | 22 Febbraio 2019 A | 89.503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | Direttore | 07 Dicembre 2017 S | 79.515 | 0 | 0 | $0 |
| Robert Nelsen | Direttore | 06 Marzo 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | Direttore | 10 Agosto 2016 J | 2.778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Direttore | 21 Giugno 2016 A | 101.009 | 0 | 0 | $0 |
| Perry A Karsen | Direttore | 23 Giugno 2015 A | — | 0 | 0 | $0 |
| Kevin P Starr | Direttore | 19 Febbraio 2015 J | 184.386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | Proprietario del 10% | 16 Dicembre 2014 P | 1.231.778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 04 Agosto 2026 S | 54.645 | 0 | 2 | $-1.064.903 |
| Jay T. Backstrom | — | 08 Luglio 2026 M | 1.447 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 05 Aprile 2021 | — | Deposito iniziale | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 depositi | 14 Novembre 2019 | — | Deposito iniziale | Struttura del capitale | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 depositi | 17 Dicembre 2014 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 57 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 34.703 NS | 30 Aprile 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,10% | 60.392 NS | 31 Maggio 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,77% | 43.269 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,60% | 110.585 NS | 30 Aprile 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 3.805 SH | 08 Agosto 2026 | Giornaliero |
| AGNG · Global X Funds | 0,28% | 7.695 NS | 31 Maggio 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 101.599 NS | 30 Aprile 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 17.290 SH | 08 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,14% | 408.719 SH | 08 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.239 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 48.730 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,13% | 113.617 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,12% | 109.727 NS | 31 Maggio 2026 | N-PORT |
| IWN · iShares Trust | 0,11% | 515.162 SH | 08 Agosto 2026 | Giornaliero |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 40.934 NS | 30 Aprile 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.166 NS | 31 Maggio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 22.172 NS | 30 Aprile 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 340.226 SH | 08 Agosto 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 788.655 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,06% | 1.508.427 SH | 08 Agosto 2026 | Giornaliero |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 9.472 NS | 30 Aprile 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 48.207 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,05% | 24.449 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2.658 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 193.306 NS | 30 Aprile 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 280.734 NS | 31 Maggio 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10.195 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.364.364 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,03% | 167.169 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,03% | 2.463 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 25.231 NS | 30 Aprile 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.079 NS | 31 Maggio 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.020 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 683.802 SH | 08 Agosto 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,02% | 2.762 NS | 30 Aprile 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 2.105 NS | 31 Maggio 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5.903 NS | 31 Maggio 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3.329 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.639 SH | 08 Agosto 2026 | Giornaliero |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.328 NS | 31 Maggio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 136.570 NS | 30 Aprile 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 8.867 NS | 30 Aprile 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 53 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25.095 NS | 31 Maggio 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 30.958 SH | 08 Agosto 2026 | Giornaliero |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1.068 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4.329 NS | 30 Aprile 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17.627 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 19.324 NS | 30 Aprile 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.536 SH | 08 Agosto 2026 | Giornaliero |